AXSM — AXSOME THERAPEUTICS INC

Ownership history in Boxer Capital, LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which Boxer Capital, LLC reported a position in AXSOME THERAPEUTICS INC (AXSM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.76% (2024 Q3)
Avg. % of fund
1.46%
First filed
2020 Q1
Last filed
2024 Q4
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q4 UNCHANGED 400,000 — 0% 1.76% $35.9M $84.61
2024 Q3 UNCHANGED 400,000 — 0% 1.76% $35.9M $89.87
2024 Q2 UNCHANGED 400,000 — 0% 1.70% $32.2M $80.50
2024 Q1 UNCHANGED 400,000 — 0% 1.58% $31.9M $79.80
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AXSM price (monthly, adj. close)

Other funds also holding AXSM

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 59.3% IRIDIAN ASSET MANAGEMENT LLC/CT 3Y 7Y 4.96% Tri Locum Partners LP 3Y 4.78% PFM Health Sciences, LP 3Y 7Y 4.58% Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.52% First Turn Management, LLC 4.32% Deep Track Capital, LP 3Y 3.74% SUPERSTRING CAPITAL MANAGEMENT LP 3.66% Rhenman & Partners Asset Management AB 3Y 7Y 1.96% Privium Fund Management B.V. 3Y 1.91%
← Back to Boxer Capital, LLC Holdings